ERBB2 and breast carcinoma: We found that high WT1 mRNA expression was associated with high histological grade, estrogen receptor (ER)-negative status, basal-like subtype, and ERBB2 (erb-b2 receptor tyrosine kinase 2, HER2) subtype in breast cancer patients.